NCT05948033 CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT05940272 Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers Status RECRUITING Phase NA
NCT05929612 A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma Status RECRUITING Phase PHASE2
NCT05922384 Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma Status RECRUITING Phase NA
NCT05921253 Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy Status RECRUITING Phase EARLY_PHASE1
NCT05907447 A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types Status UNKNOWN Phase N/A
NCT05898477 Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis Status RECRUITING Phase N/A
NCT05892146 Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction Status RECRUITING Phase NA
NCT05891821 Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) Status RECRUITING Phase PHASE2
NCT05878691 A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05873322 Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma Status RECRUITING Phase N/A
NCT05865678 Musculoskeletal Health in Adult Haematological Cancer Survivors Status RECRUITING Phase N/A
NCT05858424 Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer Status RECRUITING Phase NA
NCT05852028 A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma Status UNKNOWN Phase N/A
NCT05834751 the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma Status UNKNOWN Phase NA
NCT05813132 BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation Status COMPLETED Phase NA